Cargando…

Triple‐mutated oncolytic herpes virus for treating both fast‐ and slow‐growing tumors

Oncolytic virus therapy has emerged as a promising treatment option against cancer. To date, oncolytic viruses have been developed for malignant tumors, but the need for this new therapeutic modality also exists for benign and slow‐growing tumors. G47∆ is an oncolytic herpes simplex virus type 1 (HS...

Descripción completa

Detalles Bibliográficos
Autores principales: Fukuhara, Hiroshi, Takeshima, Yuta, Todo, Tomoki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8353919/
https://www.ncbi.nlm.nih.gov/pubmed/34036669
http://dx.doi.org/10.1111/cas.14981